nodes	percent_of_prediction	percent_of_DWPC	metapath
Dinoprostone—SLC22A1—obesity	0.186	0.574	CbGaD
Dinoprostone—CYP19A1—obesity	0.138	0.427	CbGaD
Dinoprostone—SLC22A11—Cimetidine—obesity	0.0636	0.187	CbGbCtD
Dinoprostone—SLC22A7—Cimetidine—obesity	0.0606	0.178	CbGbCtD
Dinoprostone—SLC22A2—Cimetidine—obesity	0.0431	0.127	CbGbCtD
Dinoprostone—SLC22A1—Cimetidine—obesity	0.0375	0.11	CbGbCtD
Dinoprostone—SLC22A8—Cimetidine—obesity	0.037	0.109	CbGbCtD
Dinoprostone—SLC22A6—Cimetidine—obesity	0.0258	0.0759	CbGbCtD
Dinoprostone—CYP1A2—Phentermine—obesity	0.021	0.0619	CbGbCtD
Dinoprostone—CYP1A2—Phenylpropanolamine—obesity	0.0201	0.0591	CbGbCtD
Dinoprostone—CYP1A2—Bupropion—obesity	0.0179	0.0527	CbGbCtD
Dinoprostone—CYP1A2—Cimetidine—obesity	0.0131	0.0386	CbGbCtD
Dinoprostone—PTGFR—ovarian follicle—obesity	0.0068	0.0922	CbGeAlD
Dinoprostone—CYP11A1—ovarian follicle—obesity	0.00518	0.0703	CbGeAlD
Dinoprostone—CYP19A1—ovarian follicle—obesity	0.00337	0.0457	CbGeAlD
Dinoprostone—Bimatoprost—AKR1C3—obesity	0.0014	0.819	CrCbGaD
Dinoprostone—PTGER4—respiratory system—obesity	0.00133	0.018	CbGeAlD
Dinoprostone—PTGIR—hindbrain—obesity	0.0013	0.0176	CbGeAlD
Dinoprostone—SLC51B—digestive system—obesity	0.00116	0.0157	CbGeAlD
Dinoprostone—PTGER2—adrenal cortex—obesity	0.00113	0.0154	CbGeAlD
Dinoprostone—PTGER3—respiratory system—obesity	0.00112	0.0152	CbGeAlD
Dinoprostone—SLC51B—adrenal gland—obesity	0.0011	0.0149	CbGeAlD
Dinoprostone—SLC51A—adrenal cortex—obesity	0.00109	0.0148	CbGeAlD
Dinoprostone—PTGER4—cardiovascular system—obesity	0.00102	0.0138	CbGeAlD
Dinoprostone—HPGDS—respiratory system—obesity	0.00097	0.0132	CbGeAlD
Dinoprostone—SLC51B—endocrine gland—obesity	0.000955	0.0129	CbGeAlD
Dinoprostone—PTGER2—adipose tissue—obesity	0.000912	0.0124	CbGeAlD
Dinoprostone—PTGFR—respiratory system—obesity	0.000897	0.0122	CbGeAlD
Dinoprostone—PTGER4—adipose tissue—obesity	0.000895	0.0121	CbGeAlD
Dinoprostone—SLC51B—liver—obesity	0.000861	0.0117	CbGeAlD
Dinoprostone—PTGER4—digestive system—obesity	0.000843	0.0114	CbGeAlD
Dinoprostone—SLC51A—digestive system—obesity	0.000828	0.0112	CbGeAlD
Dinoprostone—PTGER2—adrenal gland—obesity	0.000818	0.0111	CbGeAlD
Dinoprostone—PTGER4—adrenal gland—obesity	0.000803	0.0109	CbGeAlD
Dinoprostone—PTGIR—respiratory system—obesity	0.000791	0.0107	CbGeAlD
Dinoprostone—SLC51A—adrenal gland—obesity	0.000789	0.0107	CbGeAlD
Dinoprostone—PTGER3—adipose tissue—obesity	0.000758	0.0103	CbGeAlD
Dinoprostone—HPGDS—cardiovascular system—obesity	0.000743	0.0101	CbGeAlD
Dinoprostone—SLCO2A1—islet of Langerhans—obesity	0.000732	0.00993	CbGeAlD
Dinoprostone—PTGER3—digestive system—obesity	0.000714	0.00968	CbGeAlD
Dinoprostone—PTGER4—endocrine gland—obesity	0.000696	0.00945	CbGeAlD
Dinoprostone—SLCO2A1—respiratory system—obesity	0.000691	0.00938	CbGeAlD
Dinoprostone—SLC51A—endocrine gland—obesity	0.000684	0.00928	CbGeAlD
Dinoprostone—PTGER3—adrenal gland—obesity	0.00068	0.00922	CbGeAlD
Dinoprostone—SLCO4A1—islet of Langerhans—obesity	0.000673	0.00913	CbGeAlD
Dinoprostone—PTGER1—endocrine gland—obesity	0.000673	0.00912	CbGeAlD
Dinoprostone—HPGDS—adipose tissue—obesity	0.000655	0.00889	CbGeAlD
Dinoprostone—HPGDS—digestive system—obesity	0.000617	0.00837	CbGeAlD
Dinoprostone—SLC51A—liver—obesity	0.000617	0.00837	CbGeAlD
Dinoprostone—PTGFR—adipose tissue—obesity	0.000606	0.00822	CbGeAlD
Dinoprostone—PTGIR—cardiovascular system—obesity	0.000606	0.00822	CbGeAlD
Dinoprostone—PTGER3—endocrine gland—obesity	0.00059	0.008	CbGeAlD
Dinoprostone—HPGDS—adrenal gland—obesity	0.000588	0.00797	CbGeAlD
Dinoprostone—SLCO2A1—adrenal cortex—obesity	0.00058	0.00787	CbGeAlD
Dinoprostone—CYP11A1—adrenal cortex—obesity	0.000574	0.00779	CbGeAlD
Dinoprostone—PTGFR—adrenal gland—obesity	0.000544	0.00737	CbGeAlD
Dinoprostone—SLCO1C1—pituitary gland—obesity	0.000538	0.0073	CbGeAlD
Dinoprostone—SLCO1C1—adipose tissue—obesity	0.000536	0.00727	CbGeAlD
Dinoprostone—Hypertension—Phentermine—obesity	0.000535	0.005	CcSEcCtD
Dinoprostone—PTGIR—adipose tissue—obesity	0.000534	0.00725	CbGeAlD
Dinoprostone—SLCO4A1—adrenal cortex—obesity	0.000534	0.00724	CbGeAlD
Dinoprostone—Wheezing—Bupropion—obesity	0.00053	0.00496	CcSEcCtD
Dinoprostone—Tension—Diethylpropion—obesity	0.000529	0.00494	CcSEcCtD
Dinoprostone—Chest pain—Phentermine—obesity	0.000527	0.00493	CcSEcCtD
Dinoprostone—Hypersensitivity—Methamphetamine—obesity	0.000518	0.00485	CcSEcCtD
Dinoprostone—Vaginal infection—Bupropion—obesity	0.000516	0.00482	CcSEcCtD
Dinoprostone—Tachycardia—Phenylpropanolamine—obesity	0.000515	0.00482	CcSEcCtD
Dinoprostone—HPGDS—endocrine gland—obesity	0.00051	0.00691	CbGeAlD
Dinoprostone—Vision blurred—Diethylpropion—obesity	0.000508	0.00475	CcSEcCtD
Dinoprostone—Tremor—Diethylpropion—obesity	0.000505	0.00472	CcSEcCtD
Dinoprostone—Eye pain—Sibutramine—obesity	0.000504	0.00471	CcSEcCtD
Dinoprostone—PTGIR—digestive system—obesity	0.000503	0.00682	CbGeAlD
Dinoprostone—Cramps of lower extremities—Bupropion—obesity	0.000502	0.00469	CcSEcCtD
Dinoprostone—Hypersensitivity—Benzphetamine—obesity	0.0005	0.00467	CcSEcCtD
Dinoprostone—Menopausal symptoms—Orlistat—obesity	0.000498	0.00466	CcSEcCtD
Dinoprostone—SLCO2B1—respiratory system—obesity	0.000495	0.00671	CbGeAlD
Dinoprostone—Hypotension—Phenylpropanolamine—obesity	0.000493	0.00461	CcSEcCtD
Dinoprostone—Tachycardia—Phentermine—obesity	0.000493	0.00461	CcSEcCtD
Dinoprostone—SLC22A11—digestive system—obesity	0.00049	0.00665	CbGeAlD
Dinoprostone—Abdominal pain—Phendimetrazine—obesity	0.000489	0.00457	CcSEcCtD
Dinoprostone—Laryngitis—Topiramate—obesity	0.000483	0.00451	CcSEcCtD
Dinoprostone—Diarrhoea—Methamphetamine—obesity	0.000481	0.0045	CcSEcCtD
Dinoprostone—PTGIR—adrenal gland—obesity	0.000479	0.0065	CbGeAlD
Dinoprostone—Hypertonia—Bupropion—obesity	0.000479	0.00448	CcSEcCtD
Dinoprostone—SLC22A7—digestive system—obesity	0.000478	0.00649	CbGeAlD
Dinoprostone—SLCO3A1—pituitary gland—obesity	0.000473	0.00642	CbGeAlD
Dinoprostone—PTGFR—endocrine gland—obesity	0.000471	0.00639	CbGeAlD
Dinoprostone—SLCO3A1—adipose tissue—obesity	0.000471	0.00639	CbGeAlD
Dinoprostone—Dyspnoea—Phenylpropanolamine—obesity	0.000471	0.0044	CcSEcCtD
Dinoprostone—Anaphylactoid reaction—Sibutramine—obesity	0.00047	0.00439	CcSEcCtD
Dinoprostone—SLCO2A1—pituitary gland—obesity	0.000469	0.00636	CbGeAlD
Dinoprostone—SLCO2A1—adipose tissue—obesity	0.000467	0.00633	CbGeAlD
Dinoprostone—Dizziness—Methamphetamine—obesity	0.000465	0.00435	CcSEcCtD
Dinoprostone—Diarrhoea—Benzphetamine—obesity	0.000464	0.00434	CcSEcCtD
Dinoprostone—CYP11A1—adipose tissue—obesity	0.000462	0.00627	CbGeAlD
Dinoprostone—HPGDS—liver—obesity	0.00046	0.00623	CbGeAlD
Dinoprostone—Chest pain—Diethylpropion—obesity	0.000459	0.00429	CcSEcCtD
Dinoprostone—Myalgia—Diethylpropion—obesity	0.000459	0.00429	CcSEcCtD
Dinoprostone—Dizziness—Benzphetamine—obesity	0.000449	0.00419	CcSEcCtD
Dinoprostone—Deafness—Bupropion—obesity	0.000443	0.00414	CcSEcCtD
Dinoprostone—Headache—Methamphetamine—obesity	0.000441	0.00412	CcSEcCtD
Dinoprostone—Eye pain—Bupropion—obesity	0.000439	0.00411	CcSEcCtD
Dinoprostone—Myalgia—Cimetidine—obesity	0.000436	0.00408	CcSEcCtD
Dinoprostone—Arthralgia—Cimetidine—obesity	0.000436	0.00408	CcSEcCtD
Dinoprostone—Urinary retention—Sibutramine—obesity	0.000432	0.00404	CcSEcCtD
Dinoprostone—Cardiac arrest—Sibutramine—obesity	0.000432	0.00404	CcSEcCtD
Dinoprostone—SLCO4A1—pituitary gland—obesity	0.000431	0.00585	CbGeAlD
Dinoprostone—SLCO4A1—adipose tissue—obesity	0.00043	0.00583	CbGeAlD
Dinoprostone—Tachycardia—Diethylpropion—obesity	0.000429	0.00401	CcSEcCtD
Dinoprostone—ABCC5—pituitary gland—obesity	0.000429	0.00582	CbGeAlD
Dinoprostone—ABCC5—adipose tissue—obesity	0.000427	0.00579	CbGeAlD
Dinoprostone—SLC22A2—digestive system—obesity	0.000426	0.00577	CbGeAlD
Dinoprostone—PTGFR—liver—obesity	0.000425	0.00577	CbGeAlD
Dinoprostone—Hyperhidrosis—Diethylpropion—obesity	0.000425	0.00397	CcSEcCtD
Dinoprostone—Headache—Benzphetamine—obesity	0.000425	0.00397	CcSEcCtD
Dinoprostone—Hot flush—Bupropion—obesity	0.000424	0.00396	CcSEcCtD
Dinoprostone—Cramp muscle—Orlistat—obesity	0.000423	0.00396	CcSEcCtD
Dinoprostone—Diarrhoea—Phendimetrazine—obesity	0.000423	0.00396	CcSEcCtD
Dinoprostone—Dehydration—Sibutramine—obesity	0.000423	0.00395	CcSEcCtD
Dinoprostone—SLCO3A1—adrenal gland—obesity	0.000423	0.00574	CbGeAlD
Dinoprostone—Menopausal symptoms—Bupropion—obesity	0.00042	0.00393	CcSEcCtD
Dinoprostone—SLCO2A1—adrenal gland—obesity	0.000419	0.00568	CbGeAlD
Dinoprostone—Anaphylactic shock—Cimetidine—obesity	0.000418	0.00391	CcSEcCtD
Dinoprostone—SLCO1C1—endocrine gland—obesity	0.000417	0.00565	CbGeAlD
Dinoprostone—PTGIR—endocrine gland—obesity	0.000416	0.00564	CbGeAlD
Dinoprostone—CYP11A1—adrenal gland—obesity	0.000414	0.00562	CbGeAlD
Dinoprostone—Dizziness—Phendimetrazine—obesity	0.000409	0.00382	CcSEcCtD
Dinoprostone—Tachycardia—Cimetidine—obesity	0.000408	0.00382	CcSEcCtD
Dinoprostone—Asthma—Orlistat—obesity	0.000406	0.0038	CcSEcCtD
Dinoprostone—SLC22A11—endocrine gland—obesity	0.000405	0.00549	CbGeAlD
Dinoprostone—SLCO4A1—digestive system—obesity	0.000404	0.00548	CbGeAlD
Dinoprostone—Nausea—Benzphetamine—obesity	0.000403	0.00377	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Diethylpropion—obesity	0.000401	0.00375	CcSEcCtD
Dinoprostone—Abdominal pain—Phentermine—obesity	0.000399	0.00374	CcSEcCtD
Dinoprostone—Bronchospasm—Orlistat—obesity	0.000399	0.00374	CcSEcCtD
Dinoprostone—Sweating increased—Orlistat—obesity	0.000396	0.0037	CcSEcCtD
Dinoprostone—SLC22A7—endocrine gland—obesity	0.000395	0.00536	CbGeAlD
Dinoprostone—Asthma—Sibutramine—obesity	0.000393	0.00368	CcSEcCtD
Dinoprostone—Dyspnoea—Diethylpropion—obesity	0.000392	0.00367	CcSEcCtD
Dinoprostone—Hypersensitivity—Phenylpropanolamine—obesity	0.000389	0.00364	CcSEcCtD
Dinoprostone—Musculoskeletal stiffness—Topiramate—obesity	0.000388	0.00363	CcSEcCtD
Dinoprostone—Headache—Phendimetrazine—obesity	0.000387	0.00362	CcSEcCtD
Dinoprostone—SLCO4A1—adrenal gland—obesity	0.000385	0.00523	CbGeAlD
Dinoprostone—Skin discolouration—Topiramate—obesity	0.000385	0.0036	CcSEcCtD
Dinoprostone—ABCC5—adrenal gland—obesity	0.000383	0.0052	CbGeAlD
Dinoprostone—Musculoskeletal discomfort—Cimetidine—obesity	0.000381	0.00356	CcSEcCtD
Dinoprostone—Urinary retention—Bupropion—obesity	0.000377	0.00353	CcSEcCtD
Dinoprostone—PTGIR—liver—obesity	0.000375	0.00508	CbGeAlD
Dinoprostone—Dehydration—Bupropion—obesity	0.000369	0.00345	CcSEcCtD
Dinoprostone—Nausea—Phendimetrazine—obesity	0.000367	0.00343	CcSEcCtD
Dinoprostone—SLCO3A1—endocrine gland—obesity	0.000367	0.00497	CbGeAlD
Dinoprostone—Hearing impaired—Topiramate—obesity	0.000366	0.00342	CcSEcCtD
Dinoprostone—SLC22A11—liver—obesity	0.000365	0.00495	CbGeAlD
Dinoprostone—SLCO2A1—endocrine gland—obesity	0.000363	0.00493	CbGeAlD
Dinoprostone—Asthenia—Phentermine—obesity	0.000363	0.00339	CcSEcCtD
Dinoprostone—CYP11A1—endocrine gland—obesity	0.000359	0.00487	CbGeAlD
Dinoprostone—Cramp muscle—Bupropion—obesity	0.000357	0.00334	CcSEcCtD
Dinoprostone—SLC22A7—liver—obesity	0.000356	0.00483	CbGeAlD
Dinoprostone—SLCO1B1—digestive system—obesity	0.000356	0.00483	CbGeAlD
Dinoprostone—Dizziness—Phenylpropanolamine—obesity	0.000349	0.00327	CcSEcCtD
Dinoprostone—Vaginal inflammation—Topiramate—obesity	0.000348	0.00325	CcSEcCtD
Dinoprostone—Diarrhoea—Phentermine—obesity	0.000346	0.00323	CcSEcCtD
Dinoprostone—Acute coronary syndrome—Sibutramine—obesity	0.000345	0.00323	CcSEcCtD
Dinoprostone—Myocardial infarction—Sibutramine—obesity	0.000343	0.00321	CcSEcCtD
Dinoprostone—Asthma—Bupropion—obesity	0.000343	0.0032	CcSEcCtD
Dinoprostone—Bronchospasm—Bupropion—obesity	0.000337	0.00315	CcSEcCtD
Dinoprostone—Vomiting—Phenylpropanolamine—obesity	0.000336	0.00314	CcSEcCtD
Dinoprostone—SLCO2B1—adipose tissue—obesity	0.000334	0.00453	CbGeAlD
Dinoprostone—Dizziness—Phentermine—obesity	0.000334	0.00313	CcSEcCtD
Dinoprostone—SLCO4A1—endocrine gland—obesity	0.000334	0.00453	CbGeAlD
Dinoprostone—Sweating increased—Bupropion—obesity	0.000334	0.00312	CcSEcCtD
Dinoprostone—Rash—Phenylpropanolamine—obesity	0.000333	0.00311	CcSEcCtD
Dinoprostone—Dermatitis—Phenylpropanolamine—obesity	0.000333	0.00311	CcSEcCtD
Dinoprostone—Body temperature increased—Cimetidine—obesity	0.000331	0.00309	CcSEcCtD
Dinoprostone—SLCO3A1—liver—obesity	0.000331	0.00448	CbGeAlD
Dinoprostone—Vaginal infection—Topiramate—obesity	0.000328	0.00307	CcSEcCtD
Dinoprostone—SLCO2A1—liver—obesity	0.000327	0.00444	CbGeAlD
Dinoprostone—Pharyngitis—Orlistat—obesity	0.000323	0.00302	CcSEcCtD
Dinoprostone—Vomiting—Phentermine—obesity	0.000321	0.003	CcSEcCtD
Dinoprostone—Cramps of lower extremities—Topiramate—obesity	0.00032	0.00299	CcSEcCtD
Dinoprostone—SLC22A1—adipose tissue—obesity	0.000319	0.00433	CbGeAlD
Dinoprostone—Rash—Phentermine—obesity	0.000319	0.00298	CcSEcCtD
Dinoprostone—Dermatitis—Phentermine—obesity	0.000318	0.00298	CcSEcCtD
Dinoprostone—Headache—Phentermine—obesity	0.000317	0.00296	CcSEcCtD
Dinoprostone—SLCO2B1—digestive system—obesity	0.000315	0.00427	CbGeAlD
Dinoprostone—Nausea—Phenylpropanolamine—obesity	0.000314	0.00293	CcSEcCtD
Dinoprostone—Pharyngitis—Sibutramine—obesity	0.000312	0.00292	CcSEcCtD
Dinoprostone—Hypersensitivity—Cimetidine—obesity	0.000308	0.00288	CcSEcCtD
Dinoprostone—Dihomo-gamma-linolenic acid—PTGS2—obesity	0.000308	0.181	CrCbGaD
Dinoprostone—Hypertonia—Topiramate—obesity	0.000305	0.00285	CcSEcCtD
Dinoprostone—SLCO4A1—liver—obesity	0.000301	0.00409	CbGeAlD
Dinoprostone—Acute coronary syndrome—Bupropion—obesity	0.000301	0.00282	CcSEcCtD
Dinoprostone—Diarrhoea—Diethylpropion—obesity	0.000301	0.00281	CcSEcCtD
Dinoprostone—CYP19A1—adipose tissue—obesity	0.0003	0.00407	CbGeAlD
Dinoprostone—Nausea—Phentermine—obesity	0.0003	0.00281	CcSEcCtD
Dinoprostone—Asthenia—Cimetidine—obesity	0.0003	0.00281	CcSEcCtD
Dinoprostone—SLCO2B1—adrenal gland—obesity	0.0003	0.00407	CbGeAlD
Dinoprostone—ABCC5—liver—obesity	0.000299	0.00406	CbGeAlD
Dinoprostone—Myocardial infarction—Bupropion—obesity	0.000299	0.0028	CcSEcCtD
Dinoprostone—CYP1A2—respiratory system—obesity	0.000298	0.00404	CbGeAlD
Dinoprostone—ABCC4—adipose tissue—obesity	0.000296	0.00401	CbGeAlD
Dinoprostone—SLCO1B1—endocrine gland—obesity	0.000294	0.00399	CbGeAlD
Dinoprostone—Immune system disorder—Orlistat—obesity	0.000294	0.00275	CcSEcCtD
Dinoprostone—Dizziness—Diethylpropion—obesity	0.000291	0.00272	CcSEcCtD
Dinoprostone—SLCO1A2—digestive system—obesity	0.00029	0.00393	CbGeAlD
Dinoprostone—Diarrhoea—Cimetidine—obesity	0.000286	0.00268	CcSEcCtD
Dinoprostone—Angiopathy—Sibutramine—obesity	0.000285	0.00267	CcSEcCtD
Dinoprostone—Immune system disorder—Sibutramine—obesity	0.000284	0.00266	CcSEcCtD
Dinoprostone—Deafness—Topiramate—obesity	0.000282	0.00264	CcSEcCtD
Dinoprostone—Chills—Sibutramine—obesity	0.000282	0.00264	CcSEcCtD
Dinoprostone—Arrhythmia—Sibutramine—obesity	0.000281	0.00263	CcSEcCtD
Dinoprostone—Eye pain—Topiramate—obesity	0.00028	0.00262	CcSEcCtD
Dinoprostone—Vomiting—Diethylpropion—obesity	0.00028	0.00261	CcSEcCtD
Dinoprostone—ABCC4—digestive system—obesity	0.000279	0.00378	CbGeAlD
Dinoprostone—Rash—Diethylpropion—obesity	0.000277	0.00259	CcSEcCtD
Dinoprostone—Dermatitis—Diethylpropion—obesity	0.000277	0.00259	CcSEcCtD
Dinoprostone—Dizziness—Cimetidine—obesity	0.000277	0.00259	CcSEcCtD
Dinoprostone—Headache—Diethylpropion—obesity	0.000275	0.00258	CcSEcCtD
Dinoprostone—Back pain—Orlistat—obesity	0.000274	0.00256	CcSEcCtD
Dinoprostone—Pharyngitis—Bupropion—obesity	0.000272	0.00255	CcSEcCtD
Dinoprostone—Muscle spasms—Orlistat—obesity	0.000272	0.00254	CcSEcCtD
Dinoprostone—Hot flush—Topiramate—obesity	0.00027	0.00252	CcSEcCtD
Dinoprostone—CYP19A1—adrenal gland—obesity	0.000269	0.00365	CbGeAlD
Dinoprostone—Tension—Sibutramine—obesity	0.000269	0.00251	CcSEcCtD
Dinoprostone—Menopausal symptoms—Topiramate—obesity	0.000268	0.0025	CcSEcCtD
Dinoprostone—Vision blurred—Orlistat—obesity	0.000267	0.00249	CcSEcCtD
Dinoprostone—Vomiting—Cimetidine—obesity	0.000266	0.00249	CcSEcCtD
Dinoprostone—ABCC4—adrenal gland—obesity	0.000266	0.0036	CbGeAlD
Dinoprostone—SLCO1B1—liver—obesity	0.000265	0.00359	CbGeAlD
Dinoprostone—Back pain—Sibutramine—obesity	0.000265	0.00248	CcSEcCtD
Dinoprostone—Rash—Cimetidine—obesity	0.000264	0.00247	CcSEcCtD
Dinoprostone—Dermatitis—Cimetidine—obesity	0.000263	0.00246	CcSEcCtD
Dinoprostone—Muscle spasms—Sibutramine—obesity	0.000263	0.00246	CcSEcCtD
Dinoprostone—Headache—Cimetidine—obesity	0.000262	0.00245	CcSEcCtD
Dinoprostone—Nausea—Diethylpropion—obesity	0.000261	0.00244	CcSEcCtD
Dinoprostone—SLCO2B1—endocrine gland—obesity	0.00026	0.00353	CbGeAlD
Dinoprostone—Vision blurred—Sibutramine—obesity	0.000258	0.00241	CcSEcCtD
Dinoprostone—Tremor—Sibutramine—obesity	0.000257	0.0024	CcSEcCtD
Dinoprostone—Flushing—Bupropion—obesity	0.000255	0.00238	CcSEcCtD
Dinoprostone—Angiopathy—Bupropion—obesity	0.000249	0.00233	CcSEcCtD
Dinoprostone—Nausea—Cimetidine—obesity	0.000248	0.00232	CcSEcCtD
Dinoprostone—SLC22A1—endocrine gland—obesity	0.000248	0.00337	CbGeAlD
Dinoprostone—Immune system disorder—Bupropion—obesity	0.000248	0.00232	CcSEcCtD
Dinoprostone—Cough—Orlistat—obesity	0.000247	0.00231	CcSEcCtD
Dinoprostone—Chills—Bupropion—obesity	0.000246	0.0023	CcSEcCtD
Dinoprostone—Syncope—Sibutramine—obesity	0.000246	0.0023	CcSEcCtD
Dinoprostone—Arrhythmia—Bupropion—obesity	0.000245	0.00229	CcSEcCtD
Dinoprostone—Myalgia—Orlistat—obesity	0.000241	0.00225	CcSEcCtD
Dinoprostone—Chest pain—Orlistat—obesity	0.000241	0.00225	CcSEcCtD
Dinoprostone—Loss of consciousness—Sibutramine—obesity	0.000241	0.00225	CcSEcCtD
Dinoprostone—Urinary retention—Topiramate—obesity	0.00024	0.00225	CcSEcCtD
Dinoprostone—SLCO1A2—endocrine gland—obesity	0.000239	0.00324	CbGeAlD
Dinoprostone—Cough—Sibutramine—obesity	0.000239	0.00223	CcSEcCtD
Dinoprostone—Hypertension—Sibutramine—obesity	0.000236	0.00221	CcSEcCtD
Dinoprostone—Dehydration—Topiramate—obesity	0.000235	0.0022	CcSEcCtD
Dinoprostone—SLCO2B1—liver—obesity	0.000234	0.00318	CbGeAlD
Dinoprostone—Tension—Bupropion—obesity	0.000234	0.00219	CcSEcCtD
Dinoprostone—CYP19A1—endocrine gland—obesity	0.000233	0.00317	CbGeAlD
Dinoprostone—Chest pain—Sibutramine—obesity	0.000233	0.00218	CcSEcCtD
Dinoprostone—Myalgia—Sibutramine—obesity	0.000233	0.00218	CcSEcCtD
Dinoprostone—Arthralgia—Sibutramine—obesity	0.000233	0.00218	CcSEcCtD
Dinoprostone—Anaphylactic shock—Orlistat—obesity	0.000231	0.00216	CcSEcCtD
Dinoprostone—Back pain—Bupropion—obesity	0.000231	0.00216	CcSEcCtD
Dinoprostone—ABCC4—endocrine gland—obesity	0.00023	0.00312	CbGeAlD
Dinoprostone—Muscle spasms—Bupropion—obesity	0.00023	0.00215	CcSEcCtD
Dinoprostone—Vision blurred—Bupropion—obesity	0.000225	0.0021	CcSEcCtD
Dinoprostone—SLC22A1—liver—obesity	0.000224	0.00304	CbGeAlD
Dinoprostone—Tremor—Bupropion—obesity	0.000224	0.00209	CcSEcCtD
Dinoprostone—Anaphylactic shock—Sibutramine—obesity	0.000223	0.00209	CcSEcCtD
Dinoprostone—Hyperhidrosis—Orlistat—obesity	0.000223	0.00209	CcSEcCtD
Dinoprostone—Shock—Sibutramine—obesity	0.00022	0.00206	CcSEcCtD
Dinoprostone—Asthma—Topiramate—obesity	0.000218	0.00204	CcSEcCtD
Dinoprostone—Tachycardia—Sibutramine—obesity	0.000218	0.00204	CcSEcCtD
Dinoprostone—Hyperhidrosis—Sibutramine—obesity	0.000216	0.00202	CcSEcCtD
Dinoprostone—SLCO1A2—liver—obesity	0.000216	0.00293	CbGeAlD
Dinoprostone—Syncope—Bupropion—obesity	0.000214	0.002	CcSEcCtD
Dinoprostone—Sweating increased—Topiramate—obesity	0.000213	0.00199	CcSEcCtD
Dinoprostone—CYP19A1—liver—obesity	0.000211	0.00286	CbGeAlD
Dinoprostone—Musculoskeletal discomfort—Orlistat—obesity	0.00021	0.00197	CcSEcCtD
Dinoprostone—Loss of consciousness—Bupropion—obesity	0.00021	0.00196	CcSEcCtD
Dinoprostone—Hypotension—Sibutramine—obesity	0.000209	0.00195	CcSEcCtD
Dinoprostone—Cough—Bupropion—obesity	0.000208	0.00195	CcSEcCtD
Dinoprostone—ABCC4—liver—obesity	0.000208	0.00282	CbGeAlD
Dinoprostone—Paraesthesia—Orlistat—obesity	0.000207	0.00194	CcSEcCtD
Dinoprostone—Hypertension—Bupropion—obesity	0.000206	0.00193	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Sibutramine—obesity	0.000204	0.0019	CcSEcCtD
Dinoprostone—Arthralgia—Bupropion—obesity	0.000203	0.0019	CcSEcCtD
Dinoprostone—Chest pain—Bupropion—obesity	0.000203	0.0019	CcSEcCtD
Dinoprostone—Myalgia—Bupropion—obesity	0.000203	0.0019	CcSEcCtD
Dinoprostone—Paraesthesia—Sibutramine—obesity	0.000201	0.00188	CcSEcCtD
Dinoprostone—Dyspnoea—Sibutramine—obesity	0.000199	0.00186	CcSEcCtD
Dinoprostone—Pain—Orlistat—obesity	0.000197	0.00185	CcSEcCtD
Dinoprostone—Anaphylactic shock—Bupropion—obesity	0.000195	0.00182	CcSEcCtD
Dinoprostone—Shock—Bupropion—obesity	0.000192	0.00179	CcSEcCtD
Dinoprostone—Pain—Sibutramine—obesity	0.000191	0.00179	CcSEcCtD
Dinoprostone—Tachycardia—Bupropion—obesity	0.00019	0.00178	CcSEcCtD
Dinoprostone—CYP1A2—digestive system—obesity	0.000189	0.00257	CbGeAlD
Dinoprostone—Gastrointestinal pain—Orlistat—obesity	0.000189	0.00177	CcSEcCtD
Dinoprostone—Hyperhidrosis—Bupropion—obesity	0.000188	0.00176	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Sibutramine—obesity	0.000183	0.00171	CcSEcCtD
Dinoprostone—Body temperature increased—Orlistat—obesity	0.000183	0.00171	CcSEcCtD
Dinoprostone—Abdominal pain—Orlistat—obesity	0.000183	0.00171	CcSEcCtD
Dinoprostone—Hypotension—Bupropion—obesity	0.000182	0.0017	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Bupropion—obesity	0.000178	0.00166	CcSEcCtD
Dinoprostone—Abdominal pain—Sibutramine—obesity	0.000177	0.00165	CcSEcCtD
Dinoprostone—Body temperature increased—Sibutramine—obesity	0.000177	0.00165	CcSEcCtD
Dinoprostone—Paraesthesia—Bupropion—obesity	0.000175	0.00164	CcSEcCtD
Dinoprostone—Dyspnoea—Bupropion—obesity	0.000174	0.00162	CcSEcCtD
Dinoprostone—Pharyngitis—Topiramate—obesity	0.000173	0.00162	CcSEcCtD
Dinoprostone—Hypersensitivity—Orlistat—obesity	0.00017	0.00159	CcSEcCtD
Dinoprostone—Pain—Bupropion—obesity	0.000167	0.00156	CcSEcCtD
Dinoprostone—Asthenia—Orlistat—obesity	0.000166	0.00155	CcSEcCtD
Dinoprostone—Hypersensitivity—Sibutramine—obesity	0.000165	0.00154	CcSEcCtD
Dinoprostone—Flushing—Topiramate—obesity	0.000162	0.00152	CcSEcCtD
Dinoprostone—Asthenia—Sibutramine—obesity	0.00016	0.0015	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Bupropion—obesity	0.000159	0.00149	CcSEcCtD
Dinoprostone—Angiopathy—Topiramate—obesity	0.000159	0.00148	CcSEcCtD
Dinoprostone—Diarrhoea—Orlistat—obesity	0.000158	0.00148	CcSEcCtD
Dinoprostone—Immune system disorder—Topiramate—obesity	0.000158	0.00148	CcSEcCtD
Dinoprostone—Chills—Topiramate—obesity	0.000157	0.00147	CcSEcCtD
Dinoprostone—CYP1A2—endocrine gland—obesity	0.000156	0.00212	CbGeAlD
Dinoprostone—Body temperature increased—Bupropion—obesity	0.000154	0.00144	CcSEcCtD
Dinoprostone—Abdominal pain—Bupropion—obesity	0.000154	0.00144	CcSEcCtD
Dinoprostone—Diarrhoea—Sibutramine—obesity	0.000153	0.00143	CcSEcCtD
Dinoprostone—Dizziness—Orlistat—obesity	0.000153	0.00143	CcSEcCtD
Dinoprostone—Tension—Topiramate—obesity	0.000149	0.0014	CcSEcCtD
Dinoprostone—Dizziness—Sibutramine—obesity	0.000148	0.00138	CcSEcCtD
Dinoprostone—Back pain—Topiramate—obesity	0.000147	0.00138	CcSEcCtD
Dinoprostone—Vomiting—Orlistat—obesity	0.000147	0.00137	CcSEcCtD
Dinoprostone—Muscle spasms—Topiramate—obesity	0.000146	0.00137	CcSEcCtD
Dinoprostone—Rash—Orlistat—obesity	0.000146	0.00136	CcSEcCtD
Dinoprostone—Dermatitis—Orlistat—obesity	0.000145	0.00136	CcSEcCtD
Dinoprostone—Headache—Orlistat—obesity	0.000145	0.00135	CcSEcCtD
Dinoprostone—Hypersensitivity—Bupropion—obesity	0.000144	0.00134	CcSEcCtD
Dinoprostone—Vision blurred—Topiramate—obesity	0.000143	0.00134	CcSEcCtD
Dinoprostone—Tremor—Topiramate—obesity	0.000142	0.00133	CcSEcCtD
Dinoprostone—Vomiting—Sibutramine—obesity	0.000142	0.00133	CcSEcCtD
Dinoprostone—CYP1A2—liver—obesity	0.000141	0.00191	CbGeAlD
Dinoprostone—Rash—Sibutramine—obesity	0.000141	0.00132	CcSEcCtD
Dinoprostone—Dermatitis—Sibutramine—obesity	0.000141	0.00132	CcSEcCtD
Dinoprostone—Headache—Sibutramine—obesity	0.00014	0.00131	CcSEcCtD
Dinoprostone—Asthenia—Bupropion—obesity	0.00014	0.00131	CcSEcCtD
Dinoprostone—Nausea—Orlistat—obesity	0.000137	0.00128	CcSEcCtD
Dinoprostone—Syncope—Topiramate—obesity	0.000136	0.00128	CcSEcCtD
Dinoprostone—Loss of consciousness—Topiramate—obesity	0.000134	0.00125	CcSEcCtD
Dinoprostone—Diarrhoea—Bupropion—obesity	0.000133	0.00125	CcSEcCtD
Dinoprostone—Nausea—Sibutramine—obesity	0.000133	0.00124	CcSEcCtD
Dinoprostone—Cough—Topiramate—obesity	0.000133	0.00124	CcSEcCtD
Dinoprostone—Hypertension—Topiramate—obesity	0.000131	0.00123	CcSEcCtD
Dinoprostone—Chest pain—Topiramate—obesity	0.000129	0.00121	CcSEcCtD
Dinoprostone—Myalgia—Topiramate—obesity	0.000129	0.00121	CcSEcCtD
Dinoprostone—Arthralgia—Topiramate—obesity	0.000129	0.00121	CcSEcCtD
Dinoprostone—Dizziness—Bupropion—obesity	0.000129	0.0012	CcSEcCtD
Dinoprostone—Vomiting—Bupropion—obesity	0.000124	0.00116	CcSEcCtD
Dinoprostone—Rash—Bupropion—obesity	0.000123	0.00115	CcSEcCtD
Dinoprostone—Dermatitis—Bupropion—obesity	0.000123	0.00115	CcSEcCtD
Dinoprostone—Shock—Topiramate—obesity	0.000122	0.00114	CcSEcCtD
Dinoprostone—Headache—Bupropion—obesity	0.000122	0.00114	CcSEcCtD
Dinoprostone—Tachycardia—Topiramate—obesity	0.000121	0.00113	CcSEcCtD
Dinoprostone—Hyperhidrosis—Topiramate—obesity	0.00012	0.00112	CcSEcCtD
Dinoprostone—Hypotension—Topiramate—obesity	0.000116	0.00108	CcSEcCtD
Dinoprostone—Nausea—Bupropion—obesity	0.000116	0.00108	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Topiramate—obesity	0.000113	0.00106	CcSEcCtD
Dinoprostone—Paraesthesia—Topiramate—obesity	0.000111	0.00104	CcSEcCtD
Dinoprostone—Dyspnoea—Topiramate—obesity	0.000111	0.00103	CcSEcCtD
Dinoprostone—Pain—Topiramate—obesity	0.000106	0.000993	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Topiramate—obesity	0.000102	0.000949	CcSEcCtD
Dinoprostone—Abdominal pain—Topiramate—obesity	9.81e-05	0.000918	CcSEcCtD
Dinoprostone—Body temperature increased—Topiramate—obesity	9.81e-05	0.000918	CcSEcCtD
Dinoprostone—Hypersensitivity—Topiramate—obesity	9.15e-05	0.000855	CcSEcCtD
Dinoprostone—Asthenia—Topiramate—obesity	8.91e-05	0.000833	CcSEcCtD
Dinoprostone—Diarrhoea—Topiramate—obesity	8.49e-05	0.000794	CcSEcCtD
Dinoprostone—Dizziness—Topiramate—obesity	8.21e-05	0.000768	CcSEcCtD
Dinoprostone—Vomiting—Topiramate—obesity	7.89e-05	0.000738	CcSEcCtD
Dinoprostone—Rash—Topiramate—obesity	7.83e-05	0.000732	CcSEcCtD
Dinoprostone—Dermatitis—Topiramate—obesity	7.82e-05	0.000731	CcSEcCtD
Dinoprostone—Headache—Topiramate—obesity	7.78e-05	0.000727	CcSEcCtD
Dinoprostone—Nausea—Topiramate—obesity	7.37e-05	0.00069	CcSEcCtD
Dinoprostone—SLCO1B1—Metabolism—GPX1—obesity	2.36e-06	1.54e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—STAT3—obesity	2.36e-06	1.54e-05	CbGpPWpGaD
Dinoprostone—PTGFR—GPCR downstream signaling—AKT1—obesity	2.36e-06	1.54e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—CAV1—obesity	2.35e-06	1.54e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—UCP3—obesity	2.35e-06	1.53e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—UCP2—obesity	2.35e-06	1.53e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ECHS1—obesity	2.35e-06	1.53e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—HSD11B1—obesity	2.35e-06	1.53e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—APOA1—obesity	2.35e-06	1.53e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—APOB—obesity	2.33e-06	1.52e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—IL6—obesity	2.32e-06	1.52e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ADH1B—obesity	2.31e-06	1.51e-05	CbGpPWpGaD
Dinoprostone—PTGIR—GPCR downstream signaling—AKT1—obesity	2.31e-06	1.51e-05	CbGpPWpGaD
Dinoprostone—PTGER1—GPCR downstream signaling—AKT1—obesity	2.31e-06	1.51e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—MTHFR—obesity	2.31e-06	1.5e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—COMT—obesity	2.31e-06	1.5e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—CD36—obesity	2.3e-06	1.5e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—APOB—obesity	2.28e-06	1.49e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PPARGC1B—obesity	2.28e-06	1.48e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GPAM—obesity	2.28e-06	1.48e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ACSL1—obesity	2.28e-06	1.48e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—IL6—obesity	2.27e-06	1.48e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—IL6—obesity	2.27e-06	1.48e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—GNB3—obesity	2.27e-06	1.48e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PPARGC1A—obesity	2.27e-06	1.48e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—HMOX1—obesity	2.26e-06	1.48e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PPARA—obesity	2.26e-06	1.48e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—obesity	2.25e-06	1.47e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—PIK3CA—obesity	2.25e-06	1.47e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—PIK3CB—obesity	2.24e-06	1.46e-05	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—AKT1—obesity	2.23e-06	1.46e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—PTGS2—obesity	2.22e-06	1.45e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—LPL—obesity	2.22e-06	1.45e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—GNAS—obesity	2.21e-06	1.44e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—MMP9—obesity	2.21e-06	1.44e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PCK1—obesity	2.21e-06	1.44e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—HADH—obesity	2.21e-06	1.44e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—FADS1—obesity	2.21e-06	1.44e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—MYC—obesity	2.19e-06	1.43e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—AGT—obesity	2.19e-06	1.43e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—TGFB1—obesity	2.19e-06	1.43e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—MTHFR—obesity	2.18e-06	1.42e-05	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—AKT1—obesity	2.18e-06	1.42e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—LPL—obesity	2.17e-06	1.42e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—APOB—obesity	2.17e-06	1.41e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—GPX1—obesity	2.17e-06	1.41e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—MMP9—obesity	2.16e-06	1.41e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—MMP9—obesity	2.16e-06	1.41e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ACP5—obesity	2.15e-06	1.4e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—MAPK8—obesity	2.15e-06	1.4e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—APOE—obesity	2.15e-06	1.4e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PIK3CG—obesity	2.14e-06	1.4e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—AKT1—obesity	2.14e-06	1.4e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PPARA—obesity	2.14e-06	1.4e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—CAV1—obesity	2.13e-06	1.39e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—APOA1—obesity	2.12e-06	1.38e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—obesity	2.12e-06	1.38e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—CD36—obesity	2.11e-06	1.38e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—MAPK8—obesity	2.1e-06	1.37e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—MAPK8—obesity	2.1e-06	1.37e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—AKT1—obesity	2.1e-06	1.37e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—AKT1—obesity	2.1e-06	1.37e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—G6PD—obesity	2.09e-06	1.37e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—AGT—obesity	2.07e-06	1.35e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—PIK3CA—obesity	2.07e-06	1.35e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—LPL—obesity	2.07e-06	1.35e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PPARG—obesity	2.07e-06	1.35e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—SREBF2—obesity	2.07e-06	1.35e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—HK1—obesity	2.07e-06	1.35e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—CD36—obesity	2.07e-06	1.35e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—POMC—obesity	2.04e-06	1.33e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—obesity	2.03e-06	1.33e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—APOE—obesity	2.03e-06	1.33e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—INS—obesity	2.03e-06	1.32e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—GPX1—obesity	2.02e-06	1.32e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—CAV1—obesity	2.01e-06	1.31e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—APOA1—obesity	2.01e-06	1.31e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—MTHFR—obesity	2e-06	1.3e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—LPA—obesity	2e-06	1.3e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—IL6—obesity	1.99e-06	1.3e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—CD36—obesity	1.97e-06	1.28e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—STAT3—obesity	1.96e-06	1.28e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PPARA—obesity	1.96e-06	1.28e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—LPIN1—obesity	1.96e-06	1.28e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PIK3CG—obesity	1.94e-06	1.26e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—STAT3—obesity	1.92e-06	1.25e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—STAT3—obesity	1.92e-06	1.25e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.92e-06	1.25e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—obesity	1.92e-06	1.25e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—APOA5—obesity	1.92e-06	1.25e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—AGT—obesity	1.9e-06	1.24e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PIK3CD—obesity	1.88e-06	1.23e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PPARG—obesity	1.87e-06	1.22e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—MTHFR—obesity	1.86e-06	1.22e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—PIK3CA—obesity	1.86e-06	1.22e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—APOE—obesity	1.86e-06	1.21e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—ALB—obesity	1.86e-06	1.21e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—AGT—obesity	1.86e-06	1.21e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—CAV1—obesity	1.84e-06	1.2e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—POMC—obesity	1.84e-06	1.2e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—APOA1—obesity	1.84e-06	1.2e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—IL6—obesity	1.84e-06	1.2e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—AKT1—obesity	1.83e-06	1.2e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—INS—obesity	1.83e-06	1.2e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PIK3CG—obesity	1.83e-06	1.2e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PPARA—obesity	1.83e-06	1.19e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—SLC22A1—obesity	1.83e-06	1.19e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CLOCK—obesity	1.83e-06	1.19e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—MYC—obesity	1.83e-06	1.19e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—APOE—obesity	1.82e-06	1.19e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—TGFB1—obesity	1.82e-06	1.19e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—obesity	1.81e-06	1.18e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—obesity	1.8e-06	1.18e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—MYC—obesity	1.79e-06	1.17e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—MYC—obesity	1.79e-06	1.17e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—TGFB1—obesity	1.78e-06	1.16e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—TGFB1—obesity	1.78e-06	1.16e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—SULT2A1—obesity	1.78e-06	1.16e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GLP1R—obesity	1.78e-06	1.16e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PIK3R1—obesity	1.78e-06	1.16e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—NOS3—obesity	1.78e-06	1.16e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—AGT—obesity	1.77e-06	1.16e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PPARG—obesity	1.77e-06	1.15e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—DPYD—obesity	1.75e-06	1.14e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—POMC—obesity	1.75e-06	1.14e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—INS—obesity	1.74e-06	1.13e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—APOE—obesity	1.74e-06	1.13e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—CAV1—obesity	1.72e-06	1.12e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—APOA1—obesity	1.72e-06	1.12e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PIK3CD—obesity	1.7e-06	1.11e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—AKT1—obesity	1.69e-06	1.1e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PRKAR2B—obesity	1.69e-06	1.1e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—ALB—obesity	1.68e-06	1.1e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PIK3CG—obesity	1.68e-06	1.1e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—DCN—obesity	1.67e-06	1.09e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—IL6—obesity	1.65e-06	1.08e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—obesity	1.65e-06	1.07e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PIK3CB—obesity	1.64e-06	1.07e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CPT1A—obesity	1.63e-06	1.06e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PTGS2—obesity	1.63e-06	1.06e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PPARG—obesity	1.62e-06	1.06e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PIK3CD—obesity	1.61e-06	1.05e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—NOS3—obesity	1.61e-06	1.05e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PIK3R1—obesity	1.61e-06	1.05e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—POMC—obesity	1.6e-06	1.04e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—NAMPT—obesity	1.6e-06	1.04e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—ALB—obesity	1.59e-06	1.04e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—INS—obesity	1.59e-06	1.04e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—obesity	1.59e-06	1.04e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—LIPC—obesity	1.59e-06	1.04e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GCK—obesity	1.59e-06	1.04e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—APOC3—obesity	1.58e-06	1.03e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—POMC—obesity	1.57e-06	1.02e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PIK3CG—obesity	1.57e-06	1.02e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—PIK3CA—obesity	1.56e-06	1.02e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—PIK3CA—obesity	1.55e-06	1.01e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CETP—obesity	1.53e-06	9.99e-06	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—NOS3—obesity	1.52e-06	9.93e-06	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PIK3R1—obesity	1.52e-06	9.93e-06	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—AKT1—obesity	1.52e-06	9.93e-06	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—PIK3CA—obesity	1.52e-06	9.9e-06	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—PIK3CA—obesity	1.52e-06	9.9e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—SDC1—obesity	1.51e-06	9.88e-06	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PPARG—obesity	1.51e-06	9.86e-06	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—POMC—obesity	1.49e-06	9.73e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—AKR1C3—obesity	1.49e-06	9.72e-06	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PIK3CB—obesity	1.48e-06	9.69e-06	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—INS—obesity	1.48e-06	9.67e-06	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PIK3CD—obesity	1.48e-06	9.64e-06	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PTGS2—obesity	1.47e-06	9.6e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—SCARB1—obesity	1.47e-06	9.57e-06	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—ALB—obesity	1.46e-06	9.51e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—obesity	1.45e-06	9.44e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—obesity	1.43e-06	9.32e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—SREBF1—obesity	1.42e-06	9.29e-06	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PIK3CB—obesity	1.4e-06	9.17e-06	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PIK3R1—obesity	1.39e-06	9.1e-06	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—NOS3—obesity	1.39e-06	9.1e-06	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PTGS2—obesity	1.39e-06	9.08e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GOT2—obesity	1.38e-06	9.04e-06	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PIK3CD—obesity	1.38e-06	8.98e-06	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—IL6—obesity	1.37e-06	8.95e-06	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—PIK3CA—obesity	1.37e-06	8.91e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—obesity	1.37e-06	8.91e-06	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—ALB—obesity	1.36e-06	8.87e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—FASN—obesity	1.36e-06	8.84e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—BCHE—obesity	1.35e-06	8.81e-06	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—IL6—obesity	1.34e-06	8.76e-06	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—IL6—obesity	1.34e-06	8.76e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CYP2E1—obesity	1.3e-06	8.5e-06	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PIK3R1—obesity	1.3e-06	8.48e-06	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—NOS3—obesity	1.3e-06	8.48e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—NQO1—obesity	1.29e-06	8.4e-06	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PIK3CB—obesity	1.29e-06	8.4e-06	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PTGS2—obesity	1.28e-06	8.32e-06	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—AKT1—obesity	1.27e-06	8.31e-06	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—AKT1—obesity	1.27e-06	8.26e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—obesity	1.26e-06	8.23e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—obesity	1.25e-06	8.15e-06	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—AKT1—obesity	1.24e-06	8.09e-06	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—AKT1—obesity	1.24e-06	8.09e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—SLC2A4—obesity	1.23e-06	8.05e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GCG—obesity	1.23e-06	8.05e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CYCS—obesity	1.22e-06	7.95e-06	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PIK3CB—obesity	1.2e-06	7.83e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GGT1—obesity	1.2e-06	7.8e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GOT1—obesity	1.2e-06	7.8e-06	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PTGS2—obesity	1.19e-06	7.76e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—NCOA1—obesity	1.18e-06	7.68e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—STK11—obesity	1.16e-06	7.57e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CYP19A1—obesity	1.16e-06	7.57e-06	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—AKT1—obesity	1.12e-06	7.28e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—COMT—obesity	1.08e-06	7.04e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GNB3—obesity	1.06e-06	6.94e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PPARGC1A—obesity	1.06e-06	6.94e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—HMOX1—obesity	1.06e-06	6.91e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GNAS—obesity	1.04e-06	6.76e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—APOB—obesity	1.01e-06	6.62e-06	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PIK3CA—obesity	1e-06	6.53e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—LPL—obesity	9.69e-07	6.32e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GPX1—obesity	9.45e-07	6.17e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CD36—obesity	9.2e-07	6e-06	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PIK3CA—obesity	9.05e-07	5.91e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—MTHFR—obesity	8.72e-07	5.69e-06	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PIK3CA—obesity	8.56e-07	5.59e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PPARA—obesity	8.56e-07	5.58e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—AGT—obesity	8.29e-07	5.41e-06	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—AKT1—obesity	8.18e-07	5.34e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—APOE—obesity	8.12e-07	5.3e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CAV1—obesity	8.04e-07	5.25e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—APOA1—obesity	8.03e-07	5.24e-06	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PIK3CA—obesity	7.85e-07	5.12e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—obesity	7.69e-07	5.01e-06	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—AKT1—obesity	7.39e-07	4.82e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PIK3CG—obesity	7.33e-07	4.78e-06	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PIK3CA—obesity	7.32e-07	4.77e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PPARG—obesity	7.07e-07	4.61e-06	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—AKT1—obesity	7e-07	4.56e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—POMC—obesity	6.97e-07	4.55e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—INS—obesity	6.94e-07	4.53e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PIK3CD—obesity	6.44e-07	4.2e-06	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—AKT1—obesity	6.41e-07	4.18e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ALB—obesity	6.36e-07	4.15e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PIK3R1—obesity	6.08e-07	3.97e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—NOS3—obesity	6.08e-07	3.97e-06	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—AKT1—obesity	5.98e-07	3.9e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PIK3CB—obesity	5.61e-07	3.66e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PTGS2—obesity	5.56e-07	3.63e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PIK3CA—obesity	3.42e-07	2.23e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—AKT1—obesity	2.8e-07	1.82e-06	CbGpPWpGaD
